Prism Medical Announces Departure of Chief Financial Officer

TORONTO, ONTARIO -- (Marketwired) -- 06/09/16 -- Prism Medical Ltd. ("Prism Medical" or the "Company") (TSX VENTURE: PM) today announced the departure, effective June 8, 2016, of the Company's Chief Financial Officer, Rose Papastamos.

"On behalf of the Company and our Board of Directors, we thank Rose for her service to the Company and wish her well in her future endeavours," said Ross Scavuzzo, President and Chief Executive Officer of the Company.

The Company is currently in advanced negotiations with a qualified candidate for the Chief Financial Officer position and anticipates finalizing an agreement this month.

About Prism Medical Ltd.

Prism Medical is a vertically integrated manufacturer and leading provider of equipment and services used to move and handle mobility challenged individuals in a safe and dignified manner. Prism Medical's products are marketed under the brand names of Prism Medical, ErgoSafe, Waverly Glen and Nightingale in the homecare, acute care and long-term care markets throughout North America. The Company offers solutions that encourage improved care, quality of life and mobility, while seeking to lower the overall cost of the caregiving function in a number of ways, including reducing the incidence of handling-related injuries among caregivers. In addition, the Company through its network of Nightingale dealers provides an integrated suite of products and services that make home care a viable option for many people. For further information visit Prism Medical's website at www.prismmedicalltd.com or www.sedar.com.

Forward-looking statements

This announcement may contain "forward-looking statements" within the meaning of applicable securities laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Prism to be materially different from those expressed or implied by such forward-looking statements. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not undertake to update any forward-looking statements, except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
Prism Medical Ltd.
Ross Scavuzzo
Chief Executive Officer
416-260-2145
[email protected]
www.prismmedicalltd.com

Source: Prism Medical Ltd.

You May Also Be Interested In

• Philip Morris (PM) beats Q1 earnings, revenue estimates; issues upbeat guidance
• Advisory: Fortis Inc. to Hold Teleconference on May 1 to Discuss First Quarter 2024 Results and Hold Annual and Special Meeting on May 2
• Alerus Financial Corporation Reports First Quarter 2024 Net Income of $6.4 Million